These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24952301)

  • 41. Musashi1 Promotes Non-Small Cell Lung Carcinoma Malignancy and Chemoresistance via Activating the Akt Signaling Pathway.
    Lang Y; Kong X; He C; Wang F; Liu B; Zhang S; Ning J; Zhu K; Xu S
    Cell Physiol Biochem; 2017; 44(2):455-466. PubMed ID: 29141252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.
    Zhang Y; Yu JH; Lin XY; Miao Y; Han Y; Fan CF; Dong XJ; Dai SD; Wang EH
    Virchows Arch; 2011 Sep; 459(3):255-63. PubMed ID: 21818639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt/β-catentin signaling.
    Shen DJ; Jiang YH; Li JQ; Xu LW; Tao KY
    Surg Oncol; 2020 Sep; 34():31-39. PubMed ID: 32891348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell cycle-related and expression-elevated protein in tumor overexpression is associated with proliferation behaviors and poor prognosis in non-small-cell lung cancer.
    Li W; Zheng G; Xia J; Yang G; Sun J; Wang X; Wen M; Sun Y; Zhang Z; Jin F
    Cancer Sci; 2018 Apr; 109(4):1012-1023. PubMed ID: 29397041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperphosphorylation of ribosomal protein S6 predicts unfavorable clinical survival in non-small cell lung cancer.
    Chen B; Tan Z; Gao J; Wu W; Liu L; Jin W; Cao Y; Zhao S; Zhang W; Qiu Z; Liu D; Mo X; Li W
    J Exp Clin Cancer Res; 2015 Oct; 34():126. PubMed ID: 26490682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
    Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
    Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High Sam68 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Xu Y; Sun N; Zhang M; Xie J; Jiang Z
    Clin Transl Oncol; 2014 Oct; 16(10):886-91. PubMed ID: 24522888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. LYAR promotes the proliferation of non-small cell lung cancer and is associated with poor prognosis.
    Lu XN; Ju GJ; Wang YX; Wang YL; Wang K; Chen JL; Cai W; Zang QW
    Folia Histochem Cytobiol; 2021; 59(4):282-290. PubMed ID: 34890041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
    Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
    Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of MYCN promotes proliferation of non-small cell lung cancer.
    Liu K; Wang S; Liu Y; Gu J; Gu S; Xu Z; Zhang R; Wang Z; Ma H; Chen Y; Ji L
    Tumour Biol; 2016 Sep; 37(9):12855-12866. PubMed ID: 27449038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-425 regulates cell proliferation, migration and apoptosis by targeting AMPH-1 in non-small-cell lung cancer.
    Jiang L; Ge W; Geng J
    Pathol Res Pract; 2019 Dec; 215(12):152705. PubMed ID: 31685299
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine.
    Li SJ; Li Y; Cui SC; Qi Y; Zhao JJ; Liu XY; Xu P; Chen XH
    PLoS One; 2013; 8(8):e72220. PubMed ID: 23977258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatin.
    Zhao H; Xie YZ; Xing R; Sun M; Chi F; Zeng YC
    Cell Oncol (Dordr); 2017 Aug; 40(4):357-365. PubMed ID: 28567715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High expression of Cullin1 indicates poor prognosis for NSCLC patients.
    Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J
    Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.